In an ever-changing world and in a hostile region, the ability to reliably and consistently diagnose biological threats is essential to the national and global security and safety. IIBR leads the national efforts to counter any and all biological threats from intentional attacks as well as naturally-emerging diseases. Using a multi-disciplinary project strategy, combined with cutting-edge technologies, we develop methods for the detection and identification of various bio-threats. IIBR's multi-disciplinary R&D groups are engaged in the development of rapid, sensitive, and specific diagnostic methods for detection and identification of pathogens and bioterrorism threat agents. The methods are tailored for a variety of matrices such as clinical specimens, food and environmental samples, each characterized by a vastly different and complex background.
Due to the lack of effective and safe vaccines for the prevention and treatment of various bacterial diseases, antibiotics are still considered as the main strategy for prophylaxis and treatment.
Genetic based detection and identification is the most accurate and reliable way for distinguishing pathogens and bio-threat agents. We are developing ultra-rapid, highly sensitive, accurate and robust diagnostic tests utilizing state-of-the-art methods.
Immune-based detection and identification at IIBR is achieved through the development of highly sensitive, rapid, accurate and robust antibody-based diagnostic systems for various bacterial and viral pathogens and toxins.
The National Biological Laboratory, alongside its sister unit, the National Chemical Laboratory, is Israel's definitive diagnostic facility for detecting and identifying various biological threat agents as well as new, unknown emerging diseases.
We welcome you to contact us for any question or offer for collaborations.
There are some errors in your form.
the mail is recived, thank you